Brought to you by 
EndoGastric Solutions announces $21.5mm Series E
04 Jan 2010
Executive Summary
EndoGastric Solutions (minimally invasive surgeries for gastrointestinal disorders) has received commitments of up to $21.5mm in its Series E financing of equity, debt, securities, and other rights to 18 investors including returning shareholders Advanced Technology Ventures, Chicago Growth Partners, De Novo Ventures, Foundation Medical Partners, MPM Capital, and Oakwood Medical Investors. So far the company has raised $14.8mm in the round. EndoGastric Solutions will use the proceeds to expand commercialization of its EsophyX and StomaphyX natural orifice surgery devices. EndoGastric Solutions generated $79mm in its previous four financing rounds.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
EndoGastric Solutions announces $21.5mm Series E
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice